Loading patent…
AssigneeMect Corporation
InventorsRyoichi Osawa, Isao Suda, Masaaki Numata, Mamoru Sugimoto, Kenkichi Tomita, Nobuyuki Kibushi, Takayuki Ishii, Naokazu Sugiyama, Makiko Kasano, Tae Yasunaga, Makoto Tanaka, Tomoya Ogawa, Mariko Ishii
Estimating the term…
An anti-inflammatory drug comprising as the effective component at least one compound selected from the group consisting of colominic acid, partial hydrolysis products of colominic acid and pharmaceutically acceptable salts thereof. The drug is used as a drug for renal diseases, a drug for hepatitis, an immunomodulator and a drug for inhibiting the chemotaxis of neutrophil.
A method for the treatment of a renal disease, said method comprising administering an effective amount to treat netphritis of a colominic acid or a compound represented by formula ##STR2## wherein n is an integer from 0 to 10 or a pharmaceutically acceptable salt thereof to a patient in need of such treatment.
A method for the treatment of hepatitis, said method comprising administering an effective amount to treat hepatitis of colominic acid or a compound represented by the formula ##STR3## wherein n is an integer of from 0 to 10 or a pharmaceutically acceptable salt thereof, to a patient in need of such treatment.
Dependencies are inferred from the claim text.